Yudkin JS - Search Results

1

Inflammation, obesity, stress and coronary heart disease: is interleukin-6 the link?

Yudkin JS, Kumari M, Humphries SE, Mohamed-Ali V. Yudkin JS, et al. Atherosclerosis. 2000 Feb;148(2):209-14. doi: 10.1016/s0021-9150(99)00463-3. Atherosclerosis. 2000. PMID: 10657556 Review.

2

"Vasocrine" signalling from perivascular fat: a mechanism linking insulin resistance to vascular disease.

Yudkin JS, Eringa E, Stehouwer CD. Yudkin JS, et al. Lancet. 2005 May 21-27;365(9473):1817-20. doi: 10.1016/S0140-6736(05)66585-3. Lancet. 2005. PMID: 15910955

3

Angiotensin-1-converting enzyme (ACE) gene polymorphism, plasma ACE levels, and their association with the metabolic syndrome and electrocardiographic coronary artery disease in Pima Indians.

Nagi DK, Foy CA, Mohamed-Ali V, Yudkin JS, Grant PJ, Knowler WC. Nagi DK, et al. Among authors: yudkin js. Metabolism. 1998 May;47(5):622-6. doi: 10.1016/s0026-0495(98)90250-5. Metabolism. 1998. PMID: 9591757

4

Non-insulin-dependent diabetes mellitus (NIDDM) in Asians in the UK.

Yudkin JS. Yudkin JS. Diabet Med. 1996 Sep;13(9 Suppl 6):S16-8. Diabet Med. 1996. PMID: 8894475

5

Lack of evidence for secretion of plasminogen activator inhibitor-1 by human subcutaneous adipose tissue in vivo.

Yudkin JS, Coppack SW, Bulmer K, Rawesh A, Mohamed-Ali V. Yudkin JS, et al. Thromb Res. 1999 Oct 1;96(1):1-9. doi: 10.1016/s0049-3848(99)00061-4. Thromb Res. 1999. PMID: 10554079

6

Developing risk stratification charts for diabetic and nondiabetic subjects.

Yudkin JS, Chaturvedi N. Yudkin JS, et al. Diabet Med. 1999 Mar;16(3):219-27. doi: 10.1046/j.1464-5491.1999.00026.x. Diabet Med. 1999. PMID: 10227567 Clinical Trial.

7

C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue?

Yudkin JS, Stehouwer CD, Emeis JJ, Coppack SW. Yudkin JS, et al. Arterioscler Thromb Vasc Biol. 1999 Apr;19(4):972-8. doi: 10.1161/01.atv.19.4.972. Arterioscler Thromb Vasc Biol. 1999. PMID: 10195925

8

How can we best prolong life? Benefits of coronary risk factor reduction in non-diabetic and diabetic subjects.

Yudkin JS. Yudkin JS. BMJ. 1993 May 15;306(6888):1313-8. doi: 10.1136/bmj.306.6888.1313. BMJ. 1993. PMID: 8518573 Free PMC article.

9

The influence of improved glycaemic control with insulin and sulphonylureas on acute phase and endothelial markers in Type II diabetic subjects.

Yudkin JS, Panahloo A, Stehouwer C, Emeis JJ, Bulmer K, Mohamed-Ali V, Denver AE. Yudkin JS, et al. Diabetologia. 2000 Sep;43(9):1099-106. doi: 10.1007/s001250051500. Diabetologia. 2000. PMID: 11043855 Clinical Trial.

10

Low-grade inflammation may play a role in the etiology of the metabolic syndrome in patients with coronary heart disease: the HIFMECH study.

Yudkin JS, Juhan-Vague I, Hawe E, Humphries SE, di Minno G, Margaglione M, Tremoli E, Kooistra T, Morange PE, Lundman P, Mohamed-Ali V, Hamsten A; HIFMECH Study Group. Yudkin JS, et al. Metabolism. 2004 Jul;53(7):852-7. doi: 10.1016/j.metabol.2004.02.004. Metabolism. 2004. PMID: 15254876

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results